跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP-DOXAZOSIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP-DOXAZOSIN
Authorized
STANDARD
JAMP-DOXAZOSIN
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
67164805255c2413
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
67164805255c2413
Drug Approval Canada Name
JAMP-DOXAZOSIN
Product Name
JAMP-DOXAZOSIN
Status
Marketed
Status Date
2020-05-06
Original Market Date
2020-05-06
Din
02489945
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:20.00
Atc Original
C02CA04 DOXAZOSIN
Atc Name
c 02 ca 04
Aig Number
0131431003
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
DOXAZOSIN (DOXAZOSIN MESYLATE)
2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
67164805255c2413
Type
Standard
Back to Health Canada Approvals